Burns, William R <br/><br/>
Lack of specific gamma-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation.  [electronic resource] 

 -  Blood  Oct 2009 
 - 2888-99 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2009-01-199216  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>DNA Methylation<br/>Female<br/>Gene Silencing<br/>Genetic Engineering<br/>Genetic Therapy<br/>Genetic Vectors<br/>Humans<br/>Immunotherapy, Adoptive<br/>Lymphocyte Activation--genetics<br/>Male<br/>Melanoma--immunology<br/>Middle Aged<br/>Prognosis<br/>Promoter Regions, Genetic--genetics<br/>Receptors, Antigen, T-Cell--genetics<br/>Retroviridae--genetics<br/>T-Lymphocytes--immunology<br/>Terminal Repeat Sequences--genetics<br/>Young Adult